CBI’s management team is comprised of executives with experience in biopharmaceuticals and a proven track record for success:


Elena Marusakova, MD., MBA, MSc. represents the company as

executive director

Responsible for quality, medical and scientific issues, RA and pharmacovigilance

Elena was working in the pharmaceutical industry in various management and leadership positions for nine years. She was responsible for coordination, preparation and implementation of pharmaceutical products registrations, pricing, categorization of medicinal products and medical devices, quality management, medical support and pharmacovigilance.

Elena is experienced in Health Technologies Assessment. Her deep knowledge comes from the past when she worked in senior management positions at the Ministry of Health of the Slovak Republic, General Health Insurance Company and Private Health Insurance Company for seven years. Since 2009 she has been lecturing pharmacoeconomics in the Slovak Medical University. Her pharmacoeconomic contributions are frequently presented as posters at ISPOR conferences.  Considering Access she is excellent in legislation in Slovakia, EU countries and worldwide.

  • Over 20 years’ practice in the health sector
  • A specialist in elaborating pharmacoeconomic analyses and marketing of new medicinal products
  • An inspirational team leader motivating people to achieve established goals
  • Fluent in English, Spanish, Italian and Russian.